Menu UF Health Home Menu
 

Publications

• Xia G, Gao Y, Jin S, Subramony SH, Terada N, Ranum LPW, Swanson MS, Ashizawa T (2015) Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent stem cell-derived neural stem cells. Stem Cells, In press [PMID:25702800]
• Santostefano KE, Hamazaki T, Biel NM, Jin S, Umezawa A, Terada N (2015) A practical guide to induced pluripotent stem cell research using patient samples. Lab. Invest. 95:4-13
• Jia J, Jin Y, Ting B, Wu D, Yang LJ, Terada N, Wu W, Jin S (2014) Bacterial delivery of TALEN proteins for human genome editing. PLoS One 9:e91457
• Chen MJ, Lu Y, Hamazaki T, Tsai HY, Erger K, Conlon T, Elshikha AS, Li H, Srivastava A, Yao C, Brantly M, Chiodo V, Hauswirth W, Terada N, Song S (2014) Reprogramming adipose tissue derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector. Hum. Gene Ther. Methods 25:72-82
• Xia G, Santostefano K, Goodwin M, Liu J, Subramony SH, Swanson MS, Terada N and Ashizawa T (2013) Induced pluripotent stem cell as cellular model for myotonic dystrophy type 1. Cell. Reprogram. 15:166-77
• Bichsel C, Neeld D, Hamazaki T, Chang LJ, Yang LJ, Terada N and Jin S (2013) Direct reprogramming of fibroblasts to myocytes via bacterial injection of MyoD protein. Cell. Reprogram. 15: 117-25
• Xia G, Santostefano K, Hamazaki T, Liu J, Subramony SH, Terada N, and Ashizawa T (2013) Generation of human induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro. J. Mol. Neurosci. 51:237-48
• Pandian GN, Shinohara K, Ohtsuki A, Nakano Y, Masafumi M, Bando T, Nagase H, Yamada Y, Watanabe A, Terada N, Sato S, Morinaga H, and Sugiyama H (2011) Synthetic small molecules for epigenetic activation of pluripotent genes in mouse embryonic fibroblasts. Chembiochem. 12, 2822-8
• Bichsel C, Neeld DK, Hamazaki T, Chang LJ, Yang L, Terada N, and Jin S (2011) Bacterial mediated delivery of nuclear protein into pluripotent and differentiated cells. PLoS One 6, e16465
• Hankowski KE, Hamazaki T, Umezawa A, and Terada N (2011) Induced pluripotent stem cell as a next generation biomedical interface. Lab. Invest. 91, 972-7
• Gopalakrishnan S, Van Emburgh BO, Shan J, Su Z, Fields CR, Vieweg J, Hamazaki T, Schwartz PH, Terada N, and Robertson KD (2009) A novel DNMT3B splice variant expressed in tumor and pluripotent cells modulates genomic DNA methylation patterns and displays altered DNA binding. Mol. Cancer Res. 7, 1622-34